Comments
Loading...
CompuMed Analyst Ratings and Price Targets | OTC:CMPD | Benzinga
CompuMed Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for CompuMed Corp from these most-recent analyst ratings.
Analyst Ratings for CompuMed
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for CompuMed (CMPD) stock?
There is no price target for CompuMed
What is the most recent analyst rating for CompuMed (CMPD)?
There is no analyst for CompuMed
When was the last upgrade for CompuMed (CMPD)?
There is no last upgrade for CompuMed
When was the last downgrade for CompuMed (CMPD)?
There is no last downgrade for CompuMed.
When is the next analyst rating going to be posted or updated for CompuMed (CMPD)?
There is no next analyst rating for CompuMed.
Is the Analyst Rating CompuMed (CMPD) correct?
There is no next analyst rating for CompuMed.
Browse analyst ratings and price targets on all stocks.
